In this issue:
Artificial intelligence model may improve diagnosis of early-stage ovarian cancer
Four-biomarker panel detects early ovarian cancer up to 18 months earlier
Monitoring CA-125 level alone does not reliably detect progression of recurrent disease
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer
Fertility-sparing surgery safe for stage I endometrioid epithelial and mucinous ovarian cancer
SCRS plus olaparib maintenance for BRCA-mutated recurrent ovarian cancer
Surgical outcomes after SCRS in low- vs high-grade serous ovarian cancer
Interval debulking surgery feasible for advanced-stage ovarian yolk sac tumour
Anticoagulation for VTE safe during neoadjuvant chemotherapy
Survival with olaparib vs niraparib maintenance for BRCA-mutated disease
Please login below to download this issue (PDF)